Avid Bioservices (CDMO) just unveiled an update.
Avid Bioservices, Inc. has made a notable change to its Deferred Compensation Plan, as the Board of Directors agreed on an amendment ensuring all distributions from the Company Stock Fund and deferrals of Equity Awards to participants will exclusively be in the form of Company Stock. This strategic move, aimed at streamlining compensation practices, underscores the company’s commitment to aligning participant interests with the performance of its stock.
Learn more about CDMO stock on TipRanks’ Stock Analysis page.
